Potential contribution of the neurodegenerative disorders risk loci to cognitive performance in an elderly male gout population. Issue 39 (September 2017)

• Record Type: Journal Article
• Authors: Han, Lin; Jia, Zhaotong; Cao, Chunwei; Liu, Zhen; Liu, Fuqiang; Wang, Lin; Ren, Wei; Sun, Mingxia; Wang, Baoping; Li, Changgui; Chen, Li
• Other Names: Yang. Chengwu section editor.
• Is Part Of: Medicine. Volume 96:Issue 39(2017)
• Publication Date: 2017-09
• Subjects: cognitive function -- genome-wide association study -- gout -- neurodegenerative disorders risk loci -- single-nucleotide polymorphism; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000008195
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Abstract: Cognitive impairment has been described in elderly subjects with high normal concentrations of serum uric acid. However, it remains unclear if gout confers an increased poorer cognition than those in individuals with asymptomatic hyperuricemia. The present study aimed at evaluating cognitive function in patients suffering from gout in an elderly male population, and further investigating the genetic contributions to the risk of cognitive function. This study examined the cognitive function as assessed by Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) in 205 male gout patients and 204 controls. The genetic basis of these cognitive measures was evaluated by genome-wide association study (GWAS) data in 102 male gout patients. Furthermore, 7 loci associated with cognition in GWAS were studied for correlation with gout in 1179 male gout patients and 1848 healthy male controls. Compared with controls, gout patients had significantly lower MoCA scores [22.78 ± 3.01 vs 23.42 ± 2.95, P = .023, adjusted by age, body mass index (BMI), education, and emotional disorder]. GWAS revealed 7 single-nucleotide polymorphisms (SNPs) associations with MoCA test at a level of conventional genome-wide significance ( P < 9.6 × 10 –8 ). The most significant association was observed between rs12895072 and rs12434554 within the KTN1 gene ( P adjusted = 4.2 × 10 −9, P adjusted = 4.7 × 10 –9 ) at 14q22. The next best signal was in RELN gene (rs155333, P adjusted = 1.3 × 10 –8 ) at 7q22, while the other variants at rs17458357 ( P adjusted = 3.98 × 10 –8 ), rs2572683 ( P adjusted = 8.9 × 10 –8 ), rs12555895 ( P adjusted = 2.6 × 10 –8 ), and rs3764030 ( P adjusted = 9.4 × 10 –8 ) were also statistically significant. The 7 SNPs were not associated with gout in further analysis (all P > .05). Elderly male subjects with gout exhibit accelerated decline in cognition performance. Several neurodegenerative disorders risk loci were identified for genetic contributors to cognitive performance in our Chinese elderly male gout population. Larger prospective studies of the cognitive performance and genetic analysis in gout subjects are recommended. Abstract : Supplemental Digital Content is available in the text